BioViva USA
PrivateLast Round
Series A
Nov 11, 2022
Total Funding Raised
$250,000
Company Overview
BioViva USA is a biotechnology company that develops gene therapy platforms to treat severe genetic disorders and address the root causes of cellular aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioViva USA Comparables
Compare BioViva USA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unlimited Bio | 79% | |
| YouthBio Therapeutics | 78% | |
| Turn Biotechnologies | 77% | |
BioViva USA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 11, 2022 | ||||
| Early Funding | Apr 1, 2016 | ||||
| Seed | May 27, 2015 |
BioViva USA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Knowledge Life Sciences | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2016
Raised funding with participation from Deep Knowledge Life Sciences.
- May 27, 2015
$250K raised in Seed round.
BioViva USA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioViva USA's valuation, stock price, and market status.